Catherine Bollard is an Oncology physician affiliated with George Washington University Hospital. OpenAlex indexes 729 publications with 22,052 citations (h-index 74); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 Michigan Ave NW
5th Floor Main, Suite 5207
Washington, DC 200102916
Telephone
202-476-4776Registry record last updated 13 Nov 2013.
Clinical trials
- Allogeneic Virus-specific T Cell Lines (VSTs)
Sponsor: Catherine Bollard
- Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
Sponsor: Catherine Bollard
- 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
Sponsor: New York Medical College
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SWEDISH ORPHAN BIOVITRUM ABProgram year20252 payments
- National Marrow Donor ProgramProgram year20251 payment
- Janssen Research & Development, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Children's Research Institute Hematology Research Training Grant
Children'S Research Institute
FY2026$228,292T32HL110841 - Children's Research Institute Hematology Research Training Grant
Children'S Research Institute
FY2025$149,367T32HL110841
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
New England Journal of Medicine
2020 - BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo
Journal of Clinical Investigation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Roberta Debiasi, MD
George Washington University Hospital
Adelaide Robb, MD
George Washington University Hospital
Gurusher Panjrath, MD
George Washington University Hospital
Jonathan Reiner, MD
George Washington University Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”